MeSH tree: C15.378
Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international research group led by the ...
16 hours ago
0
0
Five-year relative survival rates for all cancers combined have increased to 70% for people diagnosed during 2015 to 2021 in the United States, according to the "Cancer Statistics, 2026," report, published in CA: A Cancer ...
Jan 13, 2026
0
1
Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as high in men than in women. A new study published online in Cancer provides insights that may help to ...
Jan 12, 2026
0
1
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes ...
Jan 9, 2026
0
54
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that recognizes two distinct ...
Jan 8, 2026
0
35
Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many human diseases, including cancers. However, how molecular machines—protein complexes—that control ...
Jan 8, 2026
0
6
Having an episiotomy, a surgical cut to the vagina during childbirth, doubles the risk of postpartum hemorrhage (PPH) in women with moderate or severe anemia, according to new research published in The Lancet Global Health.
Jan 8, 2026
0
27
Albumin is the most common protein in the blood, a vital molecule produced by the liver that helps maintain fluid balance and transports proteins and hormones. It also plays a key role in fighting off a lethal disease called ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in Blood Advances.
Jan 8, 2026
0
0
Does it seem like the number of people you know who have sustained knee injuries has increased recently? That's likely because of a rising incidence rate in acute knee injuries, as documented and analyzed in a 2022 study.
Jan 7, 2026
0
0
